spacer
home > pmps > spring 2018 > fight against counterfeit drugs
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Fight Against Counterfeit Drugs

Among the myriad of challenges faced by the pharmaceutical industry, the challenge of counterfeit drugs is probably the greatest. It not only causes tremendous revenue losses, but also negatively impacts a company’s reputation and brand image. Most importantly, the miseries inflicted by it on human life are simply incalculable.

Counterfeit drugs are not only threatening the confidence in healthcare professionals and health programmes, but they are also increasing the burden on healthcare systems, national medicine regulatory authorities, law enforcement, and criminal justice systems. According to industry estimates, counterfeit medicines sales are ranging from €150-€200 billion (US$163-$217 billion) per year (1). To counter this increasing threat, government bodies in most countries are devising more robust and strict regulations to control the genesis and proliferation of fake medicines. Track-and-trace, along with pharma product serialisation, is the next firm step towards winning this fight.

The Increasing Serialisation Trend

Serialisation entails encoding of each pharma product coming off a packaging line with a unique identification code that can be traced at each point throughout the supply chain. The unique identification code can be stored into an online database along with the other valuable information about the product, such as manufacturer and batch details, thus allowing for monitoring and tracing the journey of each product, from packaging line right up to the patient. Currently, serialisation regulations are at different phases of development in various countries. To match these country-specific deadlines, most of the global pharma companies need to be track-and-trace- and serialisation-ready.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
Gaurav Mohite at ACG Inspection Systems has over six years of expertise in holistic track-andtrace solutions for the pharma industry. He was part of the complete trackand- trace implementation team across all the ACG implementation globally. Gaurav had completed his master’s for Jamnalal Bajaj Institute of Management Studies, India, in marketing and bachelor degree in engineering. At the early stage of his professional career, he had worked on vision inspection systems and track-and-trace applications as developer and business analyst throughout the industry. Gaurav is currently working as product manager and working for product marketing, strategy planning, and technologic innovations.
spacer
Gaurav Mohite
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

PCI Announces Expansion of its Industry-Leading Cold Chain Infrastructure with Dedicated Minus 40 degrees C Facility

Philadelphia, USA – August 29, 2018 PCI Pharma Services (PCI), a full-service provider of specialist outsourced drug manufacturing, Clinical trial services, and commercial packaging to the global healthcare industry, is pleased to announce the completion of a purpose built -40°C storage and distribution facility at its North American Clinical Services Center of Excellence.
More info >>

White Papers

Customising the Cold Chain

World Courier

Of all the statistics emerging around the global pharmaceutical industry this year, two big numbers capture the attention of both manufacturers and their logistics partners: $248 billion, the amount the “BRIC” nations (Brazil, Russia, India and China) are poised to account for in pharmaceutical sales for by 2016; and $8 billion, the amount global pharma will spend on cold chain logistics in 2014. Why are these two numbers so noteworthy? They demonstrate that as R&D goes, so goes logistics. As products evolve to meet demands for more targeted therapies, demand for more targeted logistics solutions grows as well. And that means a need for customization for everything from clinical trial samples to finished product.
More info >>

 
Industry Events

RDD Asia 2018

14-15 November 2018, Grand Hyatt Kochi, Kerala, India

A must-attend meeting for pulmonary and nasal researchers, inhaled product developers and vendors active in this important pharmaceutical niche.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement